Solán, L., Carbonell, D., Muñiz, P., Dorado, N., Landete, E., Chicano-Lavilla, M., . . . Buño, I. (2021). Elafin as a Predictive Biomarker of Acute Skin Graft-Versus-Host Disease After Haploidentical Stem Cell Transplantation Using Post-Transplant High-Dose Cyclophosphamide. Front Immunol.
Citación estilo ChicagoSolán, Laura, et al. "Elafin As a Predictive Biomarker of Acute Skin Graft-Versus-Host Disease After Haploidentical Stem Cell Transplantation Using Post-Transplant High-Dose Cyclophosphamide." Front Immunol 2021.
Cita MLASolán, Laura, et al. "Elafin As a Predictive Biomarker of Acute Skin Graft-Versus-Host Disease After Haploidentical Stem Cell Transplantation Using Post-Transplant High-Dose Cyclophosphamide." Front Immunol 2021.